An international trial to test whether a repurposed measles, mumps and rubella vaccine could protect against Covid-19 is set to kick off in South Africa. The trial will see 30 000 health workers from the around the world take part, with 5 000 from sub-Saharan Africa. READ | SA Covid-19 vaccine trial: Why I got the experimental vaccineThe vaccine is popularly used in childhood immunisation programmes, the report said. News24 previously reported that another trial, the Oxford Covid-19 vaccine trial, had resumed after it was forced to pause following a "medical event". City Press also reported that South Africa would take part in two more Covid-19 vaccine trials, the Johnson & Johnson Ad26.Cov2-S trial and a Novavax product called NVX-CoV2373.

Source: News 24 September 21, 2020 09:00 UTC